- Home
- PTGX vs RITM Comparison
PTGX vs RITM Comparison
Compare PTGX & RITM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PTGX | RITM |
|---|---|---|
| Founded | 2006 | 2011 |
| Country | United States | United States |
| Employees | N/A | 6045 |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2B | 5.4B |
| IPO Year | 2016 | N/A |
Fundamental Metrics
Financial Performance| Metric | PTGX | RITM |
|---|---|---|
| Price | $96.84 | $9.37 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 12 | 8 |
| Target Price | ★ $100.17 | $14.56 |
| AVG Volume (30 Days) | 551.4K | ★ 8.4M |
| Earning Date | 06-01-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 10.54% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $711.26 | N/A |
| Revenue Next Year | N/A | $5.52 |
| P/E Ratio | ★ N/A | $10.21 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $39.60 | $9.13 |
| 52 Week High | $100.00 | $12.74 |
Technical Indicators
Market Signals| Indicator | PTGX | RITM |
|---|---|---|
| Relative Strength Index (RSI) | 63.95 | 26.84 |
| Support Level | $76.63 | N/A |
| Resistance Level | $100.00 | $11.24 |
| Average True Range (ATR) | 4.24 | 0.29 |
| MACD | 0.39 | -0.03 |
| Stochastic Oscillator | 81.98 | 0.00 |
Price Performance
Historical ComparisonAbout PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
About RITM Rithm Capital Corp.
Rithm Capital Corp operates as a real estate investment trust that provides capital and services to the real estate and financial services industries. The company aims to generate attractive risk-adjusted returns in all interest-rate environments through a complementary portfolio of investments and operating businesses. Its investment portfolio is composed of mortgage servicing-related assets (full and excess MSRs and servicer advances), residential securities (and associated call rights), loans (including single-family rental), and consumer loans. Its operating segments are Origination and Servicing; Investment Portfolio; Residential Transitional Lending; and Asset Management.